Axonea Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

Axonea General Information

Description

Developer of a patient base management web app intended for professionals in ophthalmology. The company's app streamlines patient treatments by drastically reducing the analysis time of patient history, and logistics associated with the generation, storage, and sending of medical consultation data, enabling ophthalmology professionals to focus on their patients and analyze data.

Contact Information

Website
www.axonea.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 5 Rue Eugene Emmanuel
  • 06000 Nice
  • France
Primary Industry
Enterprise Systems (Healthcare)
Corporate Office
  • 5 Rue Eugene Emmanuel
  • 06000 Nice
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axonea Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 27-Sep-2013 Completed Startup
To view Axonea’s complete valuation and funding history, request access »

Axonea FAQs

  • When was Axonea founded?

    Axonea was founded in 2013.

  • Where is Axonea headquartered?

    Axonea is headquartered in Nice, France.

  • What industry is Axonea in?

    Axonea’s primary industry is Enterprise Systems (Healthcare).

  • Is Axonea a private or public company?

    Axonea is a Private company.

  • What is Axonea’s current revenue?

    The current revenue for Axonea is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »